Skip to main content

Market Overview

Vetr Upgrades Johnson & Johnson Following Post-Earnings Dip


The Vetr crowd on Wednesday upgraded its rating on Johnson & Johnson (NYSE: JNJ) from 2.5 stars (Sell), issued 13 days ago, to 3 stars (Hold). Crowd sentiment at the time of the upgrade was generally negative, with 63 percent of Vetr user ratings bearish.

Vetr's downgrade comes a couple days after the consumers staples company experienced its first loss between sessions since reporting its Q3 earnings on Oct. 17. The report, which showed the company surpassing estimates for revenue and EPS by 1.87 and 5.56 percent, respectively, pushed Johnson & Johnson's stock to a new 52-week high of $144.64. It has since fallen somewhat from that high, closing Wednesday's session up slightly on the day at $142.36

See how crowdsourced ratings could help you time the market.

Curretnly, the Vetr crowd's average price target on Johnson & Johnson is down at $131.71, which is still above the average analyst price target of $125.41. Less than 2 percent of Vetr users are holding JNJ in their watch-lists.

Latest Ratings for JNJ

Jan 2021Raymond JamesMaintainsOutperform
Jan 2021Credit SuisseMaintainsOutperform
Jan 2021Morgan StanleyMaintainsOverweight

View More Analyst Ratings for JNJ
View the Latest Analyst Ratings


Related Articles (JNJ)

View Comments and Join the Discussion!

Posted-In: VetrUpgrades Price Target Crowdsourcing Analyst Ratings

Latest Ratings

ETSYRoth CapitalMaintains245.0
SRTSRoth CapitalMaintains6.0
CZRRoth CapitalMaintains134.0
WWDA DavidsonMaintains33.0
ABNBDA DavidsonMaintains210.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at